Science
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992
LONDON, July 10 — John Hardy, the British geneticist and neuroscientist who first proposed that amyloid-beta accumulation is the primary cause of…
-
Vaccination’s Journey: From Ancient Variolation to Modern Immunization
ROME, July 10 — The record of vaccination begins with a single act in 1796, when English physician Edward Jenner used material…
-
Nobel Laureate Dr. James Allison’s CTLA-4 discovery launched immunotherapy
HOUSTON, July 10 — The man who taught the immune system to fight cancer has spent the better part of three decades…
-
Sea Squirt Compound Shows Promise Against Melanoma Cells
NEW YORK, July 8 — 1%. That figure that matters: melanoma accounts for about 1% of all skin cancers, yet it causes…
-
Rye pollen compounds’ structures unlocked after decades for cancer research
CHICAGO, July 7 — Nearly 30 years ago, researchers discovered two unusual molecules in rye pollen that appeared to slow tumor growth…
-
ETH Zurich Builds Light-Controlled Switch That Wakes Dormant Lung Cancer Cells in the Lab
One number sits at the center of this new cancer research: the glucocorticoid receptor. It is a single protein. It is the…
-
Florida A&M researchers test new drug class targeting previously untreatable pancreatic cancer
For decades, the KRAS gene was considered untouchable. A single mutation in this gene drives rapid cell division in pancreatic ductal adenocarcinoma,…
-
CAR-T Therapy Eradicates Brain Tumors in Preclinical Study
LONDON, July 1 — A new immunotherapy treatment tested on animals has completely eliminated tumours in the majority of cases, raising hopes…
-
Pittsburgh Team Finds TPP1 Mutation Helps Melanoma Cells Keep Telomeres Long
PITTSBURGH — Scientists at the University of Pittsburgh School of Medicine have identified a crucial missing piece in the long-standing mystery of…
-
Nutraceutical formula shows potential in cancer treatment study
ISLAMABAD, July 1 — A new study has turned to an unexpected source in the fight against cancer: a nutraceutical formula called…
-
USC scientists unlock endless supply of cancer-fighting immune cells
LOS ANGELES, June 29 — Scientists at USC Stem Cell have developed a new method for creating a renewable and expandable supply…
-
Tiny Antarctic creature may hold key to melanoma treatment
TAMPA, June 29 — The bottom line: a toxin from a tiny sea creature collected off Antarctica has already killed melanoma cells…
-
Modified Vitamin B12 Compound Shows Early Promise Against Glioblastoma
For decades, the blood-brain barrier has been the graveyard of hope for glioblastoma patients. A new study suggests a modified vitamin might…
-
Montreal Researchers Find SLAMF6, an Internal T Cell Brake That Works Without Tumor Input
MONTREAL — The immune system has a self-destruct switch. Cancer cells have learned to flip it. And for years, doctors have been…
-
Montreal researchers identify molecular mechanism that sabotages cancer immunotherapy
MONTREAL — For a significant number of cancer patients, the most advanced immunotherapies simply stop working. Tumors that initially shrink eventually grow…
-
Montreal team finds SLAMF6 immune brake that may explain cancer drug resistance
MONTREAL — Scientists at the Montreal Clinical Research Institute (IRCM) have identified a previously unknown immune-suppressing mechanism that may explain why some…
-
CAR T-cell exhaustion switch found, disabled in mice study
In a breakthrough discovery, a team of researchers from Columbia University and University Hospital Tubingen has identified a key molecular switch responsible…
-
Scientists Capture 3D View of T Cells Attacking Cancer
Geneva, 5 June – A team of researchers from the University of Geneva and the CHUV/UNIL collaboration has produced the first detailed…
-
Breakthrough Study Challenges Notion of Irreversible Paralysis and Nerve Damage
For many years the prevailing view held that once nerve pathways in the brain or spinal cord are cut, they cannot regenerate,…
-
Dr. Barzilai Targets Aging as Key to Combating Multiple Diseases
NEW YORK, July 10 — Dr. Nir Barzilai, an Israeli-American geneticist, has spent decades researching aging as a target in biomedical research.…
-
WHO Rates Omicron Variants Nimbus and Stratus Low Risk After June 2025 Evaluation
As of June 25, 2025, the World Health Organization (WHO) continues to monitor the evolution of severe acute respiratory syndrome coronavirus 2…
-
Dana-Farber Retracts and Corrects Dozens of Papers, Then CEO Laurie Glimcher Steps Down
BOSTON, USA — Dana-Farber Cancer Institute is facing a leadership crisis and a wave of scientific corrections after an investigation uncovered research…
-
How the GLP-1 Hormone Works and Why It Became a Diabetes and Obesity Drug Target
A hormone first characterized in the 1980s has become the foundation of a major transformation in how physicians manage diabetes and obesity.…
-
Northwestern and Brigham Scientists Identify Immune Defect in Lupus and a Possible Way to Reverse It
On July 10, 2024, a joint research team from Northwestern University Feinberg School of Medicine and Harvard Medical School released a study…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992